An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the long-term safety of exenatide in patients with type 2
diabetes who were treated with exenatide in Study H8O-MC-GWAA (6-month study) or Study
H8O-MC-GWAD (12-month study). Study H8O-MC-GWAN serves as an open-ended extension to Studies
H8O-MC-GWAA and H8O-MC-GWAD.